Scientists hunt for hidden antibodies in severe seizure disorders

NCT ID NCT04421846

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects blood, spinal fluid, and brain tissue from 400 people with severe seizures (status epilepticus) or epilepsy linked to brain inflammation (dysimmune encephalitis), plus control patients. Researchers aim to find antibodies and markers of nerve cell death that could improve diagnosis and understanding of these serious conditions. Participants must be 2 years or older and enrolled in French social security.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSIMMUNE ENCEPHALITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital de la Pitié Salpêtrière

    RECRUITING

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.